ストックスクリーナーアプリを入手
4.11
3.29%
-0.14
Skye Bioscience Inc (SKYE) 最新ニュース
Skye Bioscience (SKYE) to Showcase Nimacimab Data at ADA Conference 2025 | SKYE Stock News - GuruFocus
Skye Bioscience to Present Expanded Preclinical CB1 Antibody Data at the American Diabetes Association's 85th Scientific Sessions | SKYE Stock News - GuruFocus
Skye Bioscience to Present Expanded Preclinical CB1 - GlobeNewswire
Breakthrough Obesity Drug Shows Promise: Skye Bioscience Reveals New Data at Major Diabetes Conference - Stock Titan
Skye Bioscience, Inc. (NASDAQ:SKYE) Stake Boosted by Bank of America Corp DE - Defense World
Bank of America Corp DE Acquires 10,696 Shares of Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
Cantor Fitzgerald Comments on Skye Bioscience FY2026 Earnings - MarketBeat
Selling Skye Bioscience Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - simplywall.st
Cantor Fitzgerald Forecasts Skye Bioscience FY2026 Earnings - MarketBeat
Cantor Fitzgerald Weighs in on Skye Bioscience FY2026 Earnings - Defense World
Skye Bioscience, Inc. (NASDAQ:SKYE) Receives $16.60 Consensus Target Price from Brokerages - MarketBeat
Squarepoint Ops LLC Buys Shares of 13,546 Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
Squarepoint Ops LLC Takes Position in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
Two Sigma Advisers LP Invests $32,000 in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
Two Sigma Advisers LP Purchases New Holdings in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
Jane Street Group LLC Has $102,000 Stock Position in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
Jane Street Group LLC Acquires 23,857 Shares of Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
Brokerages Set Skye Bioscience, Inc. (NASDAQ:SKYE) PT at $16.60 - Defense World
Skye Bioscience, Inc. (NASDAQ:SKYE) Shares Purchased by Deutsche Bank AG - Defense World
Deutsche Bank AG Purchases 32,054 Shares of Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
Skye Bioscience (NASDAQ:SKYE) Shares Up 24%Still a Buy? - MarketBeat
Skye Bioscience, Inc. (NASDAQ:SKYE) Shares Sold by BNP Paribas Financial Markets - Defense World
BNP Paribas Financial Markets Has $90,000 Stock Holdings in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
Northern Trust Corp Sells 5,170 Shares of Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
Skye Bioscience, Inc. (NASDAQ:SKYE) Shares Sold by Northern Trust Corp - Defense World
Skye Bioscience (NASDAQ:SKYE) Trading Up 24% – Should You Buy? - Defense World
Skye Bioscience (NASDAQ:SKYE) Trading Up 24% – Here’s What Happened - Defense World
Skye Bioscience’s SWOT analysis: obesity drug stock poised for pivotal data - Investing.com Nigeria
Skye Bioscience, Inc. (NASDAQ:SKYE) Shares Sold by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $923,000 Position in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
3 Stocks Targeting Weight Loss Market With Cannabinoid-Based Therapies - Zacks Investment Research
Arecor CEO on Skye Bioscience partnership and the value of collaborations - Proactive financial news
Skye Bioscience to Participate in Upcoming Investment Conferences - GlobeNewswire
Skye Bioscience to Participate in Upcoming Investment Conferences - GlobeNewswire Inc.
Skye Bioscience (NASDAQ:SKYE) Earns Outperform Rating from William Blair - Defense World
Skye Bioscience’s (SKYE) Outperform Rating Reiterated at William Blair - Defense World
Ensign Peak Advisors Inc Has $2.17 Million Position in Skye Bioscience, Inc. (NASDAQ:SKYE) - MarketBeat
Protagenic and Phytanix merger prompts a stock surge - BioWorld MedTech
Skye Bioscience Establishes Partnership with Arecor Therapeutics - GuruFocus
Pre-market Movers: HCTI, PTIX, BCLI, AFMD... - RTTNews
Arecor shares jump 10% on obesity drug partnership with Skye Bioscience - Proactive financial news
Arecor partners with Skye Bioscience to improve formulation of obesity drug - Proactive financial news
Skye Bioscience Partners with Arecor Therapeutics to Enhance Nimacimab Formulation for Obesity Treatment - Nasdaq
Skye Bioscience Establishes Partnership with Arecor Therapeutics to Develop Enhanced Formulation of Obesity Candidate Nimacimab - The Manila Times
Skye Bioscience Establishes Partnership with Arecor - GlobeNewswire
New Obesity Drug Breakthrough: Skye Bioscience's Once-Weekly Treatment Gets Powerful Upgrade - Stock Titan
Skye Bioscience, Inc. (NASDAQ:SKYE) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Skye Bioscience (NASDAQ:SKYE) Posts Quarterly Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat
1.11%
1.70%
大文字化:
|
ボリューム (24 時間):